Arkema commissions new US acrylic acid facility
Arkema has commissioned a new acrylic acid facility at its Clear Lake site, Texas, US, as part of the $110m investment plan announced in November 2010.
The France-based chemicals producer is planning to continue its ramp-up period during the next few months, associated with commercial qualification of newly manufactured products.
The project, which is expected to enhance reliability and increase competitiveness of the Clear Lake plant, will increase the site's manufacturing capacity to 270 kilotonnes per year.
In 2012, Arkema launched a 2-Ethyl Hexyl Acrylate (2-EHA) unit at its Bayport, Texas facility, and 2-EHA is used to produce pressure sensitive adhesives.
Currently being readied for commercial operation, the acrylic acid plant at Clear Lake is the second project of the investment programme.
Arkema is constructing a new Methyl Acrylate unit, which marks the third project of the company's investment plan.
Dedicated to supply water treatment and engineering polymers markets, the Methyl Acrylate unit is set for mechanical completion by the end of 2013.
Arkema Acrylic Monomers global group president Marie-Pierre Chevallier said the significant investment programme was a key initiative to strengthen the company's position in the North American market.
"With two key strategic and balanced production platforms in the Americas (Clear Lake and Bayport, TX) and in Europe (Carling, France), we can truly deliver on our Acrylic offering for all our customers around the world," Chevallier added.
The completion of the investment programme is expected to reinforce Arkema's position as acrylic monomers global supplier and help the company meet demand in a number of fast-growing market segments.